RecruitingNCT06332976

PrefeRences And ChemoTherapy In Breast Cancer patiEnts

Patients' Preferences for Adjuvant or Neoadjuvant Chemotherapy in Breast Cancer


Sponsor

European Institute of Oncology

Enrollment

450 participants

Start Date

Jun 4, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of the present study is to ask women treated with adjuvant or neoadjuvant chemotherapy for breast cancer what survival benefit would justify the treatment. The benefit should be evaluated in terms of Survival rate trade off and Survival time trade off value. The analyses will be conducted into three different groups of patients to value the survival benefit expected: 1. before to start the chemotherapy 2. during chemotherapy 3. after the end of chemotherapy


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is exploring patient preferences and experiences related to chemotherapy treatment in people with early or locally advanced breast cancer. Researchers want to understand what matters most to patients when receiving chemotherapy — such as side effects, convenience, and emotional impact — to help improve how treatment decisions are made and how care is delivered. **You may be eligible if:** - You have early or locally advanced breast cancer - You are currently receiving, have recently received, or are about to start adjuvant or neoadjuvant (pre- or post-surgery) chemotherapy - You can read Italian well enough to complete the study questionnaires - You are able to provide signed informed consent **You may NOT be eligible if:** - There are no exclusion criteria for this study — all eligible breast cancer patients on chemotherapy are welcome Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCompletion of questionnaires

Completion of questionnaires at the time of study entry


Locations(1)

European Institute of Oncology

Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06332976


Related Trials